Albeit statistically non-significant, or subgroup analysis showed a trend that studies that recruited dialysis patients with a high proportion of CAD (≥ 50%) or those who aged more than 65 years had a lower mortality risk if the patients received NDBBs compared with those being given DBBs.
← all excerpts
Impact of type of dialyzable beta-blockers on subsequent risk of mortality in patients receiving dialysis: A systematic review and meta-analysis.
1
—
—